Primary Citation PubMed: 18020435
Citations in PubMed
This linkout lists citations, indexed by PubMed, to the Primary Citation for this PDB ID.
Data mentions are occurrences of PDB IDs in the full text articles from the
PubMedCentral Open Access Subset
of currently about 1 million articles. For each article, the sentences containing the PDB ID are listed.
Article titles can be filtered by keywords and sorted by year.
Co-crystalization and in vitro biological characterization of 5-aryl-4-(5-substituted-2-4-dihydroxyphenyl)-1,2,3-thiadiazole Hsp90 inhibitors.
(2012) PLoS One 7
PubMed: 22984537 | PubMedCentral: PMC3439374 | DOI: 10.1371/journal.pone.0044642
Consequently, optimizing interactions between this mobile loop and future Hsp90 inhibitors could provide higher affinity binding inhibitors as has been observed for the morpholino- and monoethylamide-... roup of NVP-AUY922 (pdb 2VCI).
For atomic coordinates and structure factors, see PDB codes 2YI5 and 2VCI, respectively.
For the clinical trial candidate NVP-AUY922 (pdb 2VCI) the loop is in the apparent favored compact state.
Publication Year: 2012
RCSB PDB (citation) is managed by two members of the Research Collaboratory for Structural Bioinformatics: Rutgers and UCSD/SDSC
RCSB PDB is a member of the
The RCSB PDB is funded by a grant (DBI-1338415) from the
National Science Foundation, the
National Institutes of Health, and the
US Department of Energy.